About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

342,868 studies
in
216 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 08/05/2020.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 08/05/2020.
  • Lysine-Specific Histone Demethylase 1 (LSD1)

    The safety and efficacy of the agents and/or uses under investigation have not been established. There is no guarantee that the agents will receive health authority approval or become commercially available in any country for the uses being investigated.

     

    One mechanism of epigenetic regulation is histone modification, which can modulate chromatin structure, thereby affecting the access of cellular machinery to certain regions of DNA.1,2 Lysine-specific histone demethylase 1 (LSD1), an essential demethylation enzyme, is an epigenetic “eraser.” LSD1 is part of several chromatin complexes, some of which could potentially play a role in nucleosome remodeling, and this may regulate genes critical to stem cell differentiation and cancer development.3-5 Chromatin complexes containing LSD1 may alter chromatin structure via histone demethylation to allow for changes in gene expression.3

    Within cancer cells, LSD1 activity regulates proliferation, migration, and invasion.3,6,7 Preclinical studies suggest that LSD1 inhibition may alter gene expression, resulting in a reduction in tumor growth both in vitro and in vivo.6

    Celgene is investigating an LSD1 inhibitor, CC-90011, for the treatment of solid tumors and hematologic malignancies.

    View Related Molecules

    References

    1. Bannister A, Kouzarides T. Cell Research. 2011;21:381-395. PMID: 21321607
    2. Ververis K, et al. Biologics. 2013;7:47-60. PMID: 23459471
    3. Helin K, Dhanak D. Nature. 2013;502:480-488. PMID: 24153301
    4. Maiques-Diaz A, Somervaille TC. Epigenomics. 2016;8:1103-1116. PMID: 27479862
    5. Hino S, et al. Cancer Sci. 2016;107:1187-1192. PMID: 27375009
    6. Mohammad HP, et al. Cancer Cell. 2015;28:57-69. PMID: 26175415
    7. Schiffmann I, et al. Epigenetics. 2016;11:858-870. PMID: 27846368